(Q41736015)

8 October 2017

1 reference

title

Definition and significance of polycystic ovaries (English)

1 reference

8 October 2017

Dewailly D

1

1 reference

8 October 2017

publication date

1 June 1997

1 reference

Bailliere's clinical obstetrics and gynaecology

8 October 2017

published in

1 reference

8 October 2017

volume

11

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

349-368

1 reference

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Clinical review 56: Nonclassic adrenal hyperplasia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease The influence of various risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Ovarian stromal hypertrophy in hyperandrogenic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The polycystic ovary. I. Clinical and histologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Are women with polycystic ovary syndrome at special risk for coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Adrenal androgen production in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Metabolic regulation of androgen production by human thecal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Regulation of human dehydroepiandrosterone metabolism by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Ultrasonic findings in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

How to discriminate between normal and polycystic ovaries: transvaginal US study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The precursors of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Does early physical maturity influence breast cancer risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

The polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980041-7

7 January 2021

10.1016/S0950-3552(97)80041-7

Identifiers

DOI

1 reference

8 October 2017

1 reference